ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 132 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,637,331 | $57,405,000 | 37.04% |
| Bain Capital Life Sciences Investors, LLC | 3,700,000 | $129,722,000 | 8.05% |
| Cormorant Asset Management, LP | 4,928,756 | $172,802,000 | 7.02% |
| RA Capital Management | 5,427,655 | $190,294,000 | 2.64% |
| CM Management, LLC | 100,000 | $3,506,000 | 2.62% |
| Ghost Tree Capital, LLC | 150,000 | $5,259,000 | 1.54% |
| ORACLE INVESTMENT MANAGEMENT INC | 309,126 | $10,838,000 | 1.35% |
| Perceptive Advisors | 2,259,224 | $79,208,000 | 1.15% |
| Omega Fund Management, LLC | 164,577 | $5,770,000 | 0.65% |
| Monashee Investment Management LLC | 100,000 | $3,506,000 | 0.65% |